Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKD

Patients with CKD often progress to ESRD and develop cardiovascular disease (CVD), yet available therapies only modestly improve clinical outcomes. Observational studies report independent associations between elevated serum phosphate and fibroblast growth factor 23 (FGF23) levels and risks of ESRD,...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Am Soc Nephrol
Главные авторы: Isakova, Tamara, Ix, Joachim H., Sprague, Stuart M., Raphael, Kalani L., Fried, Linda, Gassman, Jennifer J., Raj, Dominic, Cheung, Alfred K., Kusek, John W., Flessner, Michael F., Wolf, Myles, Block, Geoffrey A.
Формат: Artigo
Язык:Inglês
Опубликовано: American Society of Nephrology 2015
Предметы:
Up Front Matters
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4587706/
https://ncbi.nlm.nih.gov/pubmed/25967123
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2015020117
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы